Active Surveillance Prostate Cancer Video Chat, February 11th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Ray E 8:25 PM
i know but if I just cut in I think others will to but if you prefer I will cut in
AnCan – Rick 8:39 PM
Dr. Sanoj Punnen https://sylvester-doctors.umiamihealth.org/provider/sanoj-punnen/525775
Hugh -Houston 8:48 PM
2nd Opinions for Biopsies: -Jonathan Epstein, MD https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org) -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions
AnCan – Rick 8:49 PM
Dr. Michael Liss https://providers.ucsd.edu/details/1477733012/urology-cancer
AnCan thanks the following sponsors for making this recording possible: Novartis, Telix, Blue Earth Diagnostics and Foundation Medicine.
Views expressed in this Recording are solely the opinion of AnCan Foundation, our Moderators and Participants.
AnCan does not accept sponsored promotion. Any drugs, protocols or devices discussed are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500Â https://www.fda.gov/media/76299/download
All AnCanâs groups are free and drop-in ⊠join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/ Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/
Join our other free and drop in groups:
Men (Only) Speaking FreelyâŠ1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
Veterans Healthcare Navigation⊠1st & 3rd Tuesdays @ 8.00 pm Eastern Schmier Room https://ancan.org/veterans/
Veterans Speaking freely⊠4th Tuesday @ @ 8.00 pm Eastern Schmier Room
Editorâs Pick:Â Cribriform complicates treatment decision; and we discuss NCI trial
Topics Discussed
Over-70 KP ‘Couple’ insisted on PSA against protocol and found 4+4 cancer – cribriform complicates Tx decision; recently Dx denovo Mx ‘Couple’ seeking their way; recurrence after 7 years may set up well for NCI trial; high Decipher and cribriform may point to doublet; NCI Playing the Long Game discussed – Dr. Paul rightly finds it antithetical; Natera trial result reports zero level ctDNA; leg pain after starting doublet HT; push the IHT 3 more months with diligent AS; estradiol vets defer conversation to next week; side effects of radiation treatment
Is Gallium – 68 the more sensitive recommended radioactive tracer to use for a PSMA-PET Scan? Just wondering if seeking the best tracer produces better results.
Active Surveillance Prostate Cancer Video Chat, January 28th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Eric- Atlanta 8:49 PM
2nd Opinions for Biopsies -Jonathan Epstein, MD Contact: jepstein@imppllc.com https://advanceduropathology.com -Ming Zhou, MD, PHD Now at Mount Sinai Health System in New York City. If you have questions for him, please contact him directly at Email: Ming.zhou@mountsinai.org -John Hopkins Pathology https://pathology.jhu.edu/patient-care/second-opinions
AnCan – Rick 8:50 PM
Recent article on finasteride/dutasteride and disease progression https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2822868?guestAccessKey=51fc10c5-3b12-4e00-903b-b8611dfbe9a5&utm_source=silverchair&utm_campaign=jama_network&utm_content=onc_weekly_highlights&utm_medium=email&adv=000002836268&mc_cid=c06ec53f6d&mc_eid=838454d636
Eric- Atlanta 9:18 PM
Latest April 2025 NCCN Guidelines for Early PCa: https://www.nccn.org/patients/guidelines/content/PDF/prostate-early-patient.pdf
AnCan – Rick 9:19 PM
Tx Dr. Dan – I recall there was something out there. Thanks
AnCan – Rick 9:22 PM
Early stage Guidelines https://www.nccn.org/patients/guidelines/content/PDF/prostate-early-patient.pdf
Hector 9:44 PM
This is now at the hypothetical level, no conclusive evidence yet: NPR: Could mRNA vaccines help fight cancer? https://www.npr.org/2022/06/05/1103178829/could-mrna-vaccines-help-fight-cancer
Active Surveillance Prostate Cancer Video Chat, January 14th, 2026
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Myriad Genetics, Telix, and Blue Earth Diagnostics.
Active Surveillance (AS) for low-risk prostate cancer involves unique challenges compared to other treatments. This online support group is designed for men and their caregivers who are currently on or considering AS. We hold four meetings monthly, recording only the second and fourth sessions. Our discussions cover a wide range of topics, including anxiety management, biopsy experiences, and the decision-making process around continuing or discontinuing AS. Newcomers are given priority to share their experiences, so we encourage you to join us.
You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/. Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/.
Chat Log:
Phil-Toronto 8:05 PM
Prostate Cancer Journal Club for Patients tomorrow at 9:00am ” can Micro U/S replace MRI for PCa Diagnosis Matt Cooperberg Laurence Klotz meded.ucsf.edu
Martin 8:13 PM
Brian, my email is martinuthe14@gmail.com. I would love to hear about your acqua ablation. Thx!
BJ 8:24 PM
Hi guys anyone have a link for the mentioned webinar tomorrow?
Phil-Toronto 8:25 PM
meded.ucsf.edu. If you google the link it should take you to the registration for the webinar tomorrow
Phil-Toronto 8:36 PM
aquablation vs. HOLEP https://www.perplexity.ai/search/80078b6b-bae2-4382-96d6-4035a1f29ba0
BJ 8:40 PM
Dan P: You mentioned a book at the beginning. if you can put the name of it on the chat. Ty
AnCan – Rick 8:50 PM
Dr. Sanjay Punnen https://sylvester-doctors.umiamihealth.org/provider/sanoj-punnen/525775
BJ 9:01 PM
Need to drop off. Thanks all for sharing so much.
AnCan – Rick 9:06 PM
Helfand webinar on AS on AnCan https://ancan.org/webinar-active-surveillance-beyond-with-dr-brian-helfand/
AnCan – Rick 9:13 PM
@RogerNorris…. PROSTATE, not prostrate.
Hi-Risk/Recurrent/Advanced PrCa Video Chat, Dec 9, 2025
AnCan thanks the following sponsors for making this recording possible: Bayer, Novartis, Johnson and Johnson, Telix, Blue Earth Diagnostics and Foundation Medicine.
Views expressed in this Recording are solely the opinion of AnCan Foundation, our Moderators and Participants.
AnCan does not accept sponsored promotion. Any drugs, protocols or devices discussed are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500Â https://www.fda.gov/media/76299/download
All AnCanâs groups are free and drop-in ⊠join us in person sometime! You can find out more about our 12 monthly prostate cancer meetings at https://ancan.org/prostate-cancer/ Sign up to receive a weekly Reminder/Newsletter for this Group or others at https://ancan.org/contact-us/
Join our other free and drop in groups:
Men (Only) Speaking FreelyâŠ1st & 3rd Thursdays @ 8.00 pm Eastern https://ancan.org/men-speaking-freely/
Veterans Healthcare Navigation⊠1st & 3rd Tuesdays @ 8.00 pm Eastern Schmier Room https://ancan.org/veterans/
Veterans Speaking freely⊠4th Tuesday @ @ 8.00 pm Eastern Schmier Room
Editorâs Pick: Lotsa confusion throughout this week! To pick just one, Signatera MRD test.
Topics Discussed
Newbie has a great HCP team – but seeking more; Mayo bamboozles this Newbie – needs more and reliable information; another Newbie chose to leave himself on ADT for 5 years – and wonders about fatigue and weight gain he’s now shed w. GLP; muscle mass with low T; Regular finds Signatera MRD test – but it’s not yet FDA approved for prostate cancer… & Dr. Jack’s been following this test a long time; Epstein downgrades Gent from 4+5 to 4+3 – Kishan & MR Linac next; elevated liver enzymes after chemo; steady as he goes with 0.03 rise; what’s pituitary’s role for testosterone; PSA testing during Pluvicto
Chat
Alexander Lalov, Pendleton, IN
sent: 4:13 PM
Is the recording going to be made public?
Eric James; Tyler TX
sent: 4:13 PM
yes, on Youtube
AnCan – rick
sent: 4:14 PM
All our Recordings are posted on YuTube – over 700
Larry (Veteran, Alaskan)
sent: 4:16 PM
Check your camera shutter at the top of your screen
Dr. Ming Zhou Mount Sinai Health System Department of Pathology, Box 1194 Annenberg Bldg. 15th FL 1468 Madison Ave New York, NY 10029 Email: Ming.zhou@mountsinai.org Telephone: (212)241-8881
Jay – those are the 2 pathologists for a 2nd opinion.
Alexander Lalov, Pendleton, IN
sent: 5:27 PM
Bary, would you post the web address, please
Alexander Lalov, Pendleton, IN
sent: 5:28 PM
Oh, Withing is the name. Thnx!
John G.
sent: 5:28 PM
https://www.youtube.com/watch?v=Ado6dItMebE Yes, even on androgen deprivation therapy (ADT) with testosterone suppressed to near-zero (castration levels), you can increase muscle mass and strength through resistance training, though gains are typically modest and focused on counteracting atrophy rather than dramatic hypertrophy.[1][3] ## Evidence from Studies Multiple clinical trials show prostate cancer patients on ADT gaining muscle mass and fiber size after 12â20 weeks of supervised resistance training, including compound lifts like squats and presses, performed 2â3 times weekly. Progressive overloadâgradually increasing weightsâprevents fiber size decline in both type I and II muscles and boosts capillarization for better performance. These adaptations occur via mechanical loading and protein synthesis pathways independent of testosterone, such as IGF-1 signaling.
Larry (Veteran, Alaskan)
sent: 5:28 PM
YMCA “Livestrong” program is designed for cancer survivors. Look it up
Larry (Veteran, Alaskan)
sent: 5:29 PM
Government funded, so it is free and includes YMCA membership for the 12 week duration,
